Showing papers by "J. Donald Easton published in 2005"

PDF

Open Access

Journal Article•DOI•

A global view of atherothrombosis:baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

[...]

Deepak L. Bhatt¹, Keith A.A. Fox¹, Werner Hacke¹, Peter B. Berger¹, Henry R. Black¹, William E. Boden¹, Patrice Cacoub¹, Eric A. Cohen¹, Mark A. Creager¹, J. Donald Easton¹, Marcus Flather¹, Steven M. Haffner¹, Christian W. Hamm¹, Graeme J. Hankey¹, S. Claiborne Johnston, Koon Hou Mak¹, J L Mas¹, G. Montalescot¹, Thomas A. Pearson¹, P. Gabriel Steg¹, Steven R. Steinhubl¹, Michael A. Weber¹, Joan E. Booth¹, Eric J. Topol¹ - Show less +20 more•Institutions (1)

Cleveland Clinic¹

01 Sep 2005-American Heart Journal

TL;DR: The CHARISMA trial will further characterize atherothrombosis and provide insight into the role of dual antiplatelet therapy in improving outcomes in patients with multiple risk factors or established vascular disease.

...read moreread less

38 citations